In Vitro Diagnostics (IVD) Market trends – Overview

The In-vitro Diagnostics Market is expected to reach $130.1 billion by 2030, at a CAGR of 4.6% during the forecast period 2023–2030. The rising prevalence of chronic diseases coupled with the increasing geriatric population, rising prevalence of acute and chronic infectious diseases, increasing funding for research activities, growing awareness regarding early disease diagnosis, growing demand for point-of-care (POC) diagnostics and rapid diagnosis, rising healthcare expenditure, and increasing funding for research activities are the key factors driving the growth of the IVD market. In addition, emerging economies, an inclination toward personalized medicine, and advancements in genomics & proteomics are expected to offer significant growth opportunities in the market.